Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report

Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report

Abstract Background Waldenström’s macroglobulinemia is a rare B-cell lymphoma. The gold standard treatment for Waldenström’s macroglobulinemia is an anti-CD20 antibody (rituximab) in combination with alkylating agents and dexamethasone. Treatment targeting the B-cell receptor such as ibrutinib (but...

Full description

Bibliographic Details
Main Authors: M. D’Aveni-Piney, M. Divoux, H. Busby-Venner, M. Muller, J. Broséus, P. Feugier
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Journal of Medical Case Reports
Subjects:
Waldenström’s macroglobulinemia
Idelalisib
Anuric renal failure
Online Access:http://link.springer.com/article/10.1186/s13256-018-1694-z

Similar Items

Similar Items